Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas
about
Pancreatic cancer from bench to bedside: molecular pathways and treatment optionsInternational consensus on the management of intraductal papillary mucinous neoplasm of the pancreasDevelopmental Pathways Direct Pancreatic Cancer Initiation from Its Cellular OriginPrevalence, Diagnosis and Management of Pancreatic Cystic Neoplasms: Current Status and Future DirectionsCyst Features and Risk of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Imaging and PathologyIntraductal Papillary Mucinous Neoplasm of the Pancreas: Current PerspectivesIntraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved?Diversity of Precursor Lesions For Pancreatic Cancer: The Genetics and Biology of Intraductal Papillary Mucinous NeoplasmIntraductal papillary mucinous neoplasm of the pancreas: an updateNext generation sequencing improves the accuracy of KRAS mutation analysis in endoscopic ultrasound fine needle aspiration pancreatic lesions.Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinomaOne of the multifocal intraductal papillary mucinous neoplasms with the clinical characteristics of mucinous cystic neoplasm.Expansion of epigenetic alterations in EFEMP1 promoter predicts malignant formation in pancreatobiliary intraductal papillary mucinous neoplasmsRecurrence and Survival After Resection of Small Intraductal Papillary Mucinous Neoplasm-associated Carcinomas (≤20-mm Invasive Component): A Multi-institutional AnalysisManagement of Patients With Pancreatic Cysts: Analysis of Possible False-Negative Cases of MalignancyClinicopathological correlates of activating GNAS mutations in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.GNAS sequencing identifies IPMN-specific mutations in a subgroup of diminutive pancreatic cysts referred to as "incipient IPMNs".Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm?Dynamics of Fukuoka Criteria and Patient Management in Pancreatic Intraductal Papillary Mucinous Neoplasms (IPMNs) During Follow-Up.Invasive carcinoma derived from branch duct-type IPMN may be a more aggressive neoplasm than that derived from main duct-type IPMN.IPMN: surgical treatment.Endoscopic ultrasound in the diagnosis of pancreatic intraductal papillary mucinous neoplasms.Pathology of pancreatic ductal adenocarcinoma: facts, challenges and future developments.The genetic classification of pancreatic neoplasia.Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.Intraductal papillary mucinous neoplasm of the pancreas - epidemiology, risk factors, diagnosis, and management.Intraductal papillary mucinous neoplasms of the pancreas: reporting clinically relevant features.Natural History of Pancreatic Cysts.Clinicophysiological outcomes after total pancreatectomy.Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.Predictors of recurrence in intraductal papillary mucinous neoplasm: experience with 183 pancreatic resections.[Duodenum-preserving total pancreatic head resection : an organ-sparing operation technique for cystic neoplasms and non-invasive malignant tumors].Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life.Multiple KRAS mutations in pancreatic adenocarcinoma: molecular features of neoplastic clones indicate the selection of divergent populations of tumor cells.European evidence-based guidelines on pancreatic cystic neoplasms.Pancreatic Cystic Lesions: Pathogenesis and Malignant Potential.
P2860
Q26747524-EF8240EE-C5F2-4C28-ADAA-CCF1D36A72BDQ26772204-CE2C31BA-7B77-4BC1-9450-1BE7C14B837FQ26774942-2889D087-AED6-4943-82AB-A2B82C28F8D2Q26783953-E24CEBA6-87F5-4E76-8FC3-0060B3D6A626Q26796498-E26C4175-261E-4691-8D6E-04805EAA8613Q28087395-3DCA1DA5-FB4B-4DD9-944C-62E63E89F8DEQ33355493-750941EB-196F-47A4-8520-6ADD27A15C03Q33635144-F2F71590-E212-44C5-8595-6EACF1679B18Q34657866-2F609499-145D-4F57-92D9-C79098E14AD5Q35087934-D53886EE-A830-4B89-8D6B-DF090853E0E3Q35228755-5436657A-EC1C-425D-95E3-F6F916550823Q36055277-6562213B-8AEE-4FD2-BBF6-F284299F508AQ36384268-87DF58A9-3363-4DF2-A8EF-1B411F930D7FQ36703314-C9C13F08-9F36-4144-9DC8-C134E0478F3EQ36985263-341F73D9-B03C-4333-BFB4-FC640FA73E00Q37117829-28E6A135-3873-4B2A-9F74-A22F508C2E61Q37162358-E3940AD8-FC52-406D-80E1-8822E8438D3AQ37346558-FD21406C-60EC-46CF-BFE2-594C54536AE9Q37589841-32240C9B-6579-4BAE-9A6E-AA3267AE2779Q37657085-ECDBE805-8810-40C4-82FF-C18916D96EE8Q37738336-3645CC02-2F4A-434C-87CE-F77A6BAFE4B9Q38119952-660D6964-573E-4CF2-917E-A5C13EFEF44CQ38133749-D309B643-EF45-483B-A681-BEB3F2F07469Q38224446-81304BC6-8D21-46C4-B44C-2C972E56E495Q38260683-87E061F5-6C5F-4B76-9993-FCFA5F9D5654Q38326191-839BAA9C-C839-41FE-9462-CB6AC2A2791FQ38434627-BBA85049-B3B8-4C80-A558-C4593EC0177CQ38690531-9687419D-A2AD-4BD2-B6E9-84F571DE8FE7Q39017824-B91DBA53-2F51-47ED-93FD-43AA39241110Q39185575-8E3499E8-5677-482C-904F-51770F1ACC99Q39557217-BBCDF27C-DFDD-4B95-A0EB-DBBB5453BDE5Q42329894-DA82C671-1955-4D46-8CFD-DB77F2EAF150Q43418185-02E73EA0-D4B9-476F-AE07-3FC528A99277Q43494998-83B58D73-0E73-418A-B37A-CD8B4D82A0F5Q46129547-81FD40AE-668F-452B-A22D-A253D27B4943Q48053437-B54A6FCB-423C-4D20-A51B-9AD9316CD5A0Q54271301-14F26A7B-DE03-42FE-B62D-BCAD8B55680EQ54943890-38D1776C-AFFD-4FB5-AB45-46C7977DDD94Q55410325-4F514910-8879-420C-80ED-7EDFD6CF4231
P2860
Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinicopathological characteri ...... nous neoplasms of the pancreas
@ast
Clinicopathological characteri ...... nous neoplasms of the pancreas
@en
Clinicopathological characteri ...... nous neoplasms of the pancreas
@nl
type
label
Clinicopathological characteri ...... nous neoplasms of the pancreas
@ast
Clinicopathological characteri ...... nous neoplasms of the pancreas
@en
Clinicopathological characteri ...... nous neoplasms of the pancreas
@nl
prefLabel
Clinicopathological characteri ...... nous neoplasms of the pancreas
@ast
Clinicopathological characteri ...... nous neoplasms of the pancreas
@en
Clinicopathological characteri ...... nous neoplasms of the pancreas
@nl
P2093
P2860
P50
P1433
P1476
Clinicopathological characteri ...... nous neoplasms of the pancreas
@en
P2093
Alexis L Norris
Athanasios C Tsiatis
Barish H Edil
Christopher L Wolfgang
Fuyuhiko Motoi
Hanno Matthaei
James R Eshleman
John L Cameron
Karen M Horton
Keith D Jackson
P2860
P304
P356
10.1097/SLA.0B013E3182378A18
P407
P577
2012-02-01T00:00:00Z